NASDAQ$ASTH
Astrana Health Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
ApolloMed's second quarter performance reflected sustained momentum and scalability, with revenue up 29%, net income attributable to ApolloMed up 10%, and adjusted EBITDA up 44% compared to a year ago.
Apollo Medical Holdings, Inc. reported strong second quarter results with a 29% increase in revenue and a 10% increase in net income attributable to ApolloMed. The company reiterated its full-year 2023 guidance.
- Revenue increased by 29% compared to the previous year.
- Net income attributable to ApolloMed increased by 10% compared to the previous year.
- Adjusted EBITDA increased by 44% compared to the previous year.
- The company reiterated its previously provided guidance for full-year 2023.
Headline financials
Revenue & EPS history
Astrana Health · Revenue · Quarterly
$348M
Forward guidance
ApolloMed reiterated its full-year 2023 guidance for total revenue, net income, EBITDA, Adjusted EBITDA, and EPS - diluted, based on the Company’s existing business, current view of existing market conditions and assumptions.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+0.7%
Avg return
Earnings day
-2.1%
Avg return
5 days after
+2.1%
Avg return
30 days after
40%
23 / 57 earnings
Positive
+83.3%
Q3 2011
Best reaction
-40.5%
Q2 2012
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +29.4% | +22.5% | +20.6% | |
| Q3 2025 | -23.4% | -29.4% | -33.8% | |
| Q1 2025 | -11.1% | -20.8% | -24.5% | |
| Q4 2024 | -26.8% | +5.0% | +16.1% | |
| Q3 2024 | -21.1% | -27.9% | -30.4% | |
| Q2 2024 | -1.4% | -1.8% | +0.1% | |
| Q1 2024 | -0.7% | +1.5% | +8.0% | |
| Q4 2023 | +2.3% | +1.8% | -1.9% | |
| Q3 2023 | +9.3% | +2.9% | +13.4% | |
| Q2 2023 | +4.2% | +3.5% | -17.4% | |
| Q1 2023 | +5.4% | +7.0% | -0.8% | |
| Q4 2022 | +6.9% | +5.2% | +15.2% | |
| Q3 2022 | +8.4% | +8.9% | -14.5% | |
| Q2 2022 | -4.3% | -11.0% | -29.3% | |
| Q1 2022 | -0.5% | -5.4% | -26.4% | |
| Q4 2021 | -2.0% | -11.0% | -7.0% | |
| Q3 2021 | +14.7% | +30.5% | +0.8% | |
| Q2 2021 | -11.8% | -10.7% | -12.9% | |
| Q1 2021 | +4.5% | +4.7% | +10.9% | |
| Q4 2020 | +9.1% | +8.8% | +8.3% | |
| Q3 2020 | -1.2% | -1.6% | +0.5% | |
| Q2 2020 | +1.8% | +2.4% | +7.9% | |
| Q1 2020 | -10.4% | -11.6% | +13.1% | |
| Q4 2019 | -12.9% | -24.0% | +7.0% | |
| Q3 2019 | -2.9% | -0.9% | +25.0% | |
| Q2 2019 | -5.0% | +4.8% | +31.1% | |
| Q1 2019 | -1.2% | -4.3% | -29.7% | |
| Q4 2018 | -6.4% | -8.3% | -6.9% | |
| Q3 2018 | +26.3% | +4.0% | -4.6% | |
| Q2 2018 | -13.7% | -23.3% | -32.2% | |
| Q4 2017 | +10.8% | -6.3% | +2.1% | |
| Q1 2018 | +10.8% | -6.3% | +2.1% | |
| Q3 2017 | +3.9% | +3.9% | +140.0% | |
| Q2 2017 | +0.0% | +0.0% | -10.5% | |
| Q1 2017 | +0.0% | +6.7% | +36.7% | |
| Q1 2016 | +4.0% | +4.0% | +0.0% | |
| Q3 2016 | -4.8% | — | — | |
| Q2 2016 | -12.9% | — | — | |
| Q1 2015 | -6.5% | — | — | |
| Q3 2015 | -3.2% | — | — | |
| Q2 2015 | +0.0% | — | — | |
| Q2 2014 | +15.6% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | +1.6% | — | — | |
| Q2 2013 | +13.5% | — | — | |
| Q1 2013 | -13.3% | — | — | |
| Q4 2012 | -2.2% | — | — | |
| Q3 2012 | -9.1% | — | — | |
| Q2 2012 | -40.5% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | +83.3% | — | — | |
| Q2 2011 | +0.5% | — | — | |
| Q1 2011 | -0.5% | — | — | |
| Q4 2010 | -3.9% | — | — | |
| Q3 2010 | +19.0% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | -2.1% | — | — | |
| Q4 2009 | +9.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro